Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3

Human Reproduction

Volumn 18, Issue 2, 2003, Pages 323-327

  Fanchin, Renato ^a   Schonäuer, Luca Maria ^a   Righini, Claudia ^a   Guibourdenche, Jean ^a   Frydman, René ^a   Taieb, Joëlle ^a  

^a Dept Obstet Gynecol/Reprod Med ^*  (France)

Author keywords

Anti M llerian hormone; Antral follicles; Endocrine profile; M llerian inhibiting substance (MIS); Ovarian reserve

Indexed keywords

ESTRADIOL; FOLLITROPIN; INHIBIN B; LUTEINIZING HORMONE; MARKER; MUELLERIAN INHIBITING FACTOR;

ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOCRINE SYSTEM; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE FERTILITY; FEMALE INFERTILITY; FOLLICULAR PHASE; FOLLITROPIN BLOOD LEVEL; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; OVARY FOLLICLE; OVARY FUNCTION; PREDICTION; PROSPECTIVE STUDY; SERUM; TRANSVAGINAL ECHOGRAPHY;

FALLOPIA;

EID: 0037323643     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/deg042     Document Type: Article

References (26)

1. Baarends, W.M., Uilenbroek, J.T., Kramer, P., Hoogerbrugge, J.W., Van Leeuwen, E.C., Themmen, A.P. and Grootegoed, J.A. (1995) Anti-mullerian hormone and anti-mullerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth. Endocrinology, 136, 4951-4562.
2. Chang, M.Y., Chiang, C.H., Hsieh, T.T., Soong, Y.K. and Hsu, K.H. (1998) Use of the antral follicle count to predict the outcome of assisted reproductive technologies. Fertil. Steril., 69, 505-510.
3. Cook, C.L., Siow, Y., Taylor, S. and Fallat, M.E. (2000) Serum mullerian-inhibiting substance levels during normal menstrual cycles. Fertil. Steril., 73, 859-861.
4. Cook, C.L., Siow, Y., Brenner, A.G. and Fallat, M.E. (2002) Relationship between serum müllerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women. Fertil. Steril., 77, 141-146.
5. De Vet, A., Laven, J.S., De Jong, F.H., Themmen, A.P. and Fauser, B.C. (2002) Anti-mullerian hormone serum levels: A putative marker for ovarian aging. Fertil. Steril., 77, 357-362.
6. Durlinger, A.L., Guijters, M.J., Kramer, P., Karels, B., Kumar, T.R., Matzuk, M.M., Rose, U.M., De Jong, F.H., Uilenbroek, J.T., Grootegoed, J.A. and Themmen, A.P. (2001) Anti-Mullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology, 142, 4891-4899.
7. Durlinger, A.L., Gruijters, M.J., Kramer, P., Karels, B., Ingraham, H.A., Nachtigal, M.W., Uilenbroek, J.T., Grootegoed, J.A. and Themmen, A.P. (2002) Anti-Mullerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology, 143, 1076-1084.
8. Groome, N.P., Illingworth, P.J., O'Brien, M., Pai, R., Rodger, F.E., Mather, J.P. and McNeilly, A.S. (1996) Measurement of dimeric inhibin B throughout the human menstrual cycle. J. Clin. Endocrinol. Metab., 81, 1401-1405.
9. Hotelling, H. (1940) The selection of variates for use in prediction with some comments on the problem of nuisance parameters. Ann. Math. Stat., 11, 271-283.
10. Hudson, P.L., Dougas, I., Donahoe, P.K., Cate, R.L., Epstein, J., Pepinsky, R.B. and MacLaughlin, D.T. (1990) An immunoassay to detect human mullerian inhibiting substance in males and females during normal development. J. Clin. Endocrinol. Metab., 70, 16-22.
11. Ingraham, H.A., Hirokawa, Y., Roberts, L.M., Mellon, S.H., McGee, E., Nachtigal, M.W. and Visser, J.A. (2000) Autocrine and paracrine Mullerian inhibiting substance hormone signaling in reproduction. Recent Prog. Horm. Res., 55, 53-67.
12. Josso, N., Racine, C., Di Clemente, N., Rey, R. and Xavier, F. (1998) The role of anti-Mullerian hormone in gonadal development. Mol. Cell. Endocrinol., 145, 3-7.
13. Josso, N., Di Clemente, N. and Gouedard, L. (2001) Anti-Mullerian hormone and its receptors. Mol. Cell. Endocrinol., 179, 25-32.
14. László, F.J.M.M., Bancsi, L.F., Broekmans, F.J., Eijkemans, M.J., De Jong, F.H., Habbema, J.D. and Te Velde, E.R. (2002) Predictors of poor ovarian response in in vitro fertilization: A prospective study comparing basal markers of ovarian reserve. Fertil. Steril., 77, 328-336.
15. Lee, M.M. and Donahoe, P.K. (1993) Mullerian inhibiting substance: A gonadal hormone with multiple functions. Endocr. Rev., 14, 152-164.
16. Long, W.Q., Ranchin, V., Pautie, P., Belville, C., Denizot, P., Cailla, H., Lhomme, C., Picard, J.Y., Bidart, J.M. and Rey, R. (2000) Detection of minimal levels of serum anti-Mullerian hormone during follow-up of patients with ovarian granulosa cell tumor by means of a highly sensitive enzyme-linked immunosorbent assay. J. Clin. Endocrinol. Metab., 85, 540-544.
17. Mais, V., Cetel, N.S., Muse, K.N., Quigley, M.E., Reid, R.L. and Yen, S.S. (1987) Hormonal dynamics during luteal-follicular transition. J. Clin. Endocrinol. Metab., 64, 1109-1114.
18. McGee, E.A., Smith, R., Spears, N., Nachtigal, M.W., Ingraham, H. and Hsueh, A.J. (2001) Mullerian inhibitory substance induces growth of rat preantral ovarian follicles. Biol. Reprod., 64, 293-298.
19. Pepinsky, R.B., Sinclair, L.K., Chow, E.P., Mattaliano, R.J., Manganaro, T.F., Donahoe, P.K. and Cate, R.L. (1988) Proteolytic processing of Mullerian inhibiting substance produces a transforming growth factor-β-like fragment. J. Biol. Chem., 263, 18961-18964.
20. Rajpert-De Meyts, E., Jorgensen, N., Graem, N., Muller, J., Cate, R.L. and Skakkebaek, N.E. (1999) Expression of anti-Mullerian hormone during normal and pathological gonadal development: Association with differentiation of Sertoli and granulosa cells. J. Clin. Endocrinol. Metab., 84, 3836-3844.
21. Reuss, M.L., Kline, J., Santos, R., Levin, B. and Timor-Tritsch, I. (1996) Age and the ovarian follicle pool assessed with transvaginal ultrasonography. Am. J. Obstet. Gynecol., 174, 624-627.
22. Seifer, D.B., MacLaughlin, D.T., Christian, B.P., Feng, B. and Shelden, R.M. (2002) Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil. Steril., 77, 468-471.
23. Sharara, F.I. and McClamrock, H.D. (1999) The effect of aging on ovarian volume measurements in infertile women. Obstet. Gynecol., 94, 57-60.
24. Thomas, J.D. and Rubin, D.N. (1998) Tissue harmonic imaging: Why does it work? J. Am. Soc. Echocardiogr., 11, 803-808.
25. Vigier, B., Picard, J.Y., Tran, D., Legeai, L. and Josso, N. (1984) Production of anti-Müllerian hormone: Another homology between Sertoli and granulosa cells. Endocrinology, 114, 1315-1320.
26. Welt, C.K., Martin, K.A., Taylor, A.E., Lambert-Messerlian, G.M., Crowley, W.F Jr., Smith, J.A., Schoenfield, D.A and Hall, J.E. (1997) Frequency modulation of follicle-stimulating hormone (FSH) during the luteal-follicular transition: Evidence for FSH control of inhibin B in normal women. J. Clin. Endocrinol. Metab., 82, 2645-2652.